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The interactions between T-cell receptor (TCR) and peptide-major-histocompatibility complex (pMHC), which
enable T-cell development and initiate adaptive immune responses, have been intensively studied. However, a
central issue of how lipid rafts affect the TCR-pMHC interactions remains unclear. Here, by using a statistical-
mechanical membrane model, we show that the binding affinity of TCR and pMHC anchored on two apposing
cell membranes is significantly enhanced because of the lipid raft-induced signaling protein aggregation. This
finding may provide an alternative insight into the mechanism of T-cell activation triggered by very low densities
of pMHC. In the case of cell-substrate adhesion, our results indicate that the loss of lateral mobility of the proteins
on the solid substrate leads to the inhibitory effect of lipid rafts on TCR-pMHC interactions. Our findings help
to understand why different experimental methods for measuring the impact of lipid rafts on the receptor-ligand
interactions have led to contradictory conclusions.
DOI: 10.1103/PhysRevE.95.012403
I. INTRODUCTION
The prominent features in the adaptive immune response
involve the activation of mature T lymphocytes (T cells) and
the selection and maturation of immature T cells [1]. These
critical events are all initiated by the interactions of the T-cell
receptor (TCR) on the surface of T cells with a particular
ligand, peptide-major-histocompatibility complex (pMHC) on
the surface of antigen presenting cells (APCs) [2,3]. The
recognition of pMHC by TCR then leads to the intracellular
signal transduction events that are required for T cells develop-
ment and effector functions. The earliest signaling event that
occurs after TCR ligation by pMHC is the phosphorylation of
immunoreceptor tyrosine-based activation motifs (ITAMs) in
the CD3 subunits of TCR by the Src family tyrosine kinases,
Lck and Fyn. This phosphorylation results in the recruitment of
the Syk family kinase ZAP-70 to the TCR/CD3 complex where
it is activated. Activated ZAP-70 subsequently phosphorylates
the transmembrane adaptor linker for activation of T cells
(LAT), which in turn promotes the recruitment and activation
of numerous downstream adaptors or scaffold proteins to favor
TCR signaling cascades [4–8]. Analogously, upon the binding
of TCR to pMHC, thymocytes will undergo either positive
or negative selection with similar signaling pathways and
associated components involved in mature T-cell activation.
Positive selection selects thymocytes with TCR capable
of binding pMHC, whereas negative selection induces the
apoptosis in thymocytes expressing TCR with high affinity
for pMHC [9,10].
Given the significance and complexity of TCR signal-
ing transduction, a large number of studies have been
conducted to understand the mechanisms of each step in
signaling cascades [5,8,11,12]. Recently, the implications
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of lipid rafts in T-cell activation and thymocyte selection
have been investigated [4,13–23]. Lipid rafts, cholesterol-
and sphingolipid-enriched membrane microdomains, exist as
distinct liquid-ordered phases that float freely as stable entities
in the liquid-disordered matrix of the plasma membrane. They
are also resistant to extraction with nonionic detergents. A
central feature of lipid rafts is that of selectively recruiting
classes of proteins [4,24,25]. Evidence from experiments
indicates that many T-cell signaling proteins, including but
not limited to TCR, CD4, CD8, Lck, LAT, Ras, Fyn,
and ZAP-70, are present in lipid rafts [13]. It is widely
accepted that lipid rafts serving as signaling platforms can
facilitate protein-protein interactions on a single membrane
by virtue of spatial proximity of participating components,
thereby promoting signaling transduction [4,26]. However,
the role of lipid rafts in the primordial step of the TCR
signal transduction, TCR-pMHC ligation, has rarely been
taken into consideration (Fig. 1). By performing an in situ
experiment, Anderson et al. demonstrated that MHC class II
molecules constitutively reside in lipid rafts. They showed that
disruption of lipid rafts on APCs by the treatment of cells
with raft-disrupting-agent, methyl-β-cyclodextrin (MβCD),
inhibits the MHC class II-restricted antigen presentation [27].
They presumed that the increased local concentration of MHC
class II molecules in lipid rafts is crucial for the initiation
of immune responses, which provides important insights,
whereas experimental data of cell-mimetic systems obtained
by Murai et al. conversely suggest that lipid rafts exert
negative control on the receptor-ligand interactions [28], and
the corresponding regulatory mechanism is not yet resolved.
Taken together, the fundamental mechanism of how lipid rafts
might drive TCR-pMHC interactions and the reason for the
different experimental results remain unclear and quantitative
analysis is lacking.
In the present study, we will focus on the functional role of
lipid raft characteristics in the TCR-pMHC interactions with
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FIG. 1. Illustration of antigen recognition via TCR-pMHC inter-
actions in the presence of lipid rafts.
a recently developed statistical-mechanical membrane model.
We find that, consistent with the experimental results [27], the
antigen presentation is facilitated by the protein aggregation
induced by lipid raft characteristics. Moreover, based on the
quantitative analysis that the presence of the lipid rafts leads
to a significant increase in the two-dimensional (2D) binding
affinity, we provide an alternative insight into the mechanism
by which T cells can be efficiently activated by pMHC at
very low densities. Importantly, we show that lipid rafts can
either positively or negatively regulate the receptor-ligand
interactions depending on the experimental methods, which
helps to reconcile the seemingly discrepant experimental
results.
II. MODEL AND METHOD
In this study, we use the Monte Carlo (MC) simula-
tion method to investigate the effects of lipid rafts on the
TCR-pMHC interactions. The simulation process involves
the fluctuation of membranes, and the lateral diffusion of
signaling proteins and lipid rafts on the membranes. In the MC
simulations, the cell membrane is represented by a discretized
elastic sheet consisting of N×N quadratic lattices of size a2.
Each lattice can be only occupied by a TCR or a pMHC
molecule, which undergoes undirected diffusion described
by the hopping process. Whether a binding event of TCR
and pMHC occurs or not depends on the distribution of
signaling proteins and the local separation of binding sites. The
entropic repulsive force, induced by thermal fluctuations of
membrane shapes [29], and specific attraction force, mediated
by TCRs and pMHCs, determine the local separations and
configurations of the membranes. Here, we use the square-well
potential to model the TCR-pMHC interactions. The lipid rafts
are modeled as two-dimensional patches with low diffusivity.
Here, as studied by Nicolau et al. [30,31], we introduce a
ratio ρ = Draft/Dnonraft of diffusion coefficient of the signaling
proteins inside (Draft) and outside (Dnonraft) lipid rafts to
describe the extent of the slowdown diffusion of signaling
proteins within lipid rafts. Lipid rafts are assumed to diffuse
in a manner analogous to signaling proteins. To satisfy the
condition of detailed balance, the microdomains in the T-cell
membrane and the APC membrane move independently of
TCRs and pMHCs, respectively. In this work, we employ two
types of raft models, static and dynamic, to study their roles in
the TCR-pMHC interactions. In the static model, lipid rafts are
represented as square-shaped patches with defined sizes and
corresponding diffusion rates. Both shape and size of lipid rafts
are fixed throughout a simulation run. To describe the dynamic
behavior of lipid rafts in vivo, the neighboring elementary
units of lipid rafts experience, in addition to the hard-square
repulsion interaction, an attractive cis interaction Uαα in the
dynamic raft model, where the notation α denotes the raft
membrane patches. In the MC simulations, we investigate the
impact of dynamic lipid rafts on the TCR-pMHC interactions
by varying the value of cis interaction Uαα .
In view of the fact that proteins can be included or
excluded from lipid rafts to variable extents, we introduce a
parameter Uaffinity to define the change in the energy for
a signaling protein entering into a lipid raft from nonraft
regions. When a signaling protein attempts to move from
nonraft to raft patches, this movement is accepted or rejected
according to the Metropolis criterion. Similarly, the acceptance
probability of a raft diffusion attempt depends on the raft
affinity for signaling proteins and the change of the number
of proteins in this microdomain. In particular, once hopping
into a raft (or nonraft) region, a signaling protein will be
permanently captured in that region for Uaffinity → −∞ (or
Uaffinity → +∞) through its hopping process. Additionally,
we incorporate the interaction potential terms Wmem, Wpro, and
Wraft into the Hamiltonian of the system to prevent the overlaps
of two apposing membranes, neighboring signaling proteins,
and lipid rafts, respectively (see Appendix for details).
In this study, we perform 5 × 107 attempted local moves
per membrane lattice and simulate membranes with a size
up to 100 × 100 lattices and periodic boundary conditions.
The effective bending rigidity κ of the membrane has a
typical value of 12.5 kBT [32] with kB being the Boltzmann
constant and T being the absolute temperature. In our model,
the default values of TCR and pMHC concentrations are,
respectively, 200 and 60 molecules/μm2, which are consistent
with experimental conditions [32,33]. These signaling proteins
are randomly distributed through the nonraft regions of the
membranes at the beginning of the simulations. According to
Ref. [34], the complex length lc of TCR-pMHC complexes
is set to be 15 nm. Unless otherwise specified, we fix the
depth of the square-well potential Ubinding = 5.0 kBT and
potential range lv = 1 nm [35] to define the TCR-pMHC
interactions.
III. RESULTS AND DISCUSSIONS
A. Effects of lipid raft characteristics on the
TCR-pMHC interactions
On the whole, the presence of lipid rafts will lead to a change
in the overall diffusion rate of proteins on the membranes
and an increase in local density of proteins in raft or nonraft
regions. To facilitate the analysis, the static raft model is used
here to uncover the underlying mechanism of the effect of lipid












IMPACT OF LIPID RAFTS ON THE T-CELL- . . . PHYSICAL REVIEW E 95, 012403 (2017)
(a)
(b)
FIG. 2. (a) Snapshots of the spatial distribution of signaling
proteins and lipid rafts in the T-cell and APC membranes at
equilibrium. (b) Time evolution of TCR-pMHC complex fraction for
three values of ρ. The number of permanently captured proteins in
each lipid raft is 1. Each lipid raft here has a fixed area of 50 × 50 nm2.
The parameter values used in the simulation are shown in Table I.
We first investigate the role of the diffusion rate of signaling
proteins in the TCR-pMHC interactions by changing the
diffusion ratio ρ. To rule out the influence of raft-induced
protein aggregation, each lipid raft is allowed to carry only
one signaling protein. At the beginning of the MC simulations,
each raft is set to have high inherent affinity, Uaffinity → −∞,
for signaling proteins. However, if the chosen raft has already
contained a protein during the simulation run, the raft affinity
of this microdomain for proteins outside this area becomes
Uaffinity → +∞. Meanwhile, the number of lipid rafts is the
same as that of signaling proteins in each membrane. As a
result, at equilibrium the number of signaling proteins in each
raft Npro will be the same and equal to 1 [Fig. 2(a)]. As shown
in Fig. 2(b), although the time needed to reach equilibrium
increases with smaller diffusion ratio ρ, all systems with
different ρ converge to the same level of TCR-pMHC complex
fraction in the long run. Throughout this study, the complex
fraction is defined as the ratio between the numbers of
TCR-pMHC complexes and pMHCs. Consistently, the data
shown in Fig. 3 indicate that the protein area concentration in
lipid rafts and the TCR-pMHC complex fraction at equilibrium
are independent of the parameters ρ and φ. Here, φ refers to
the ratio of the diffusion coefficients of lipid rafts and signaling
proteins. These results, which are in conformity with the
standard thermodynamics theory, reveal that the diffusion rate
of signaling proteins has no impact on the complex fraction at
equilibrium. Moreover, this conclusion can be further verified
by virtue of the existing theory. In the absence of lipid
rafts, the membrane fraction Pb within binding range for
long receptor-ligand complexes has a linear relationship with
rescaled effective potential depth u and behaves as (Krobath
et al. [35])
Pb ≈ cu = ca2(κ/kBT ) l2v [R][L]eU/kBT , (1)
with numerical prefactor c ∼= 13 for small Pb  0.2, where [R]
and [L] are the area concentrations of unbound receptors and
unbound ligands, respectively. Here, we obtain the dependence
of Pb on u by varying the area concentration of signaling
proteins in each membrane. For simplicity, the number of
signaling protein (or lipid raft) in one membrane is set to be the
same as that in the apposing membrane in Fig. 4. Meanwhile,
the inherent affinity of a raft for protein molecules outside
that ordered membrane domain undergoes a transition from
Uaffinity → −∞ to Uaffinity → +∞ if the protein number
inside that raft reaches a specified value Npro. If each lipid raft
is permitted to contain only one signaling protein, our results
are in good agreement with the theoretical data in the absence
of lipid rafts [Fig. 4(b)], which in turn demonstrates the validity
of our model as well. It is important to note that although the
raft diffusion coefficient has no effect on the complex fraction
at equilibrium (Fig. 3), we use the Saffman-Delbruck equa-
tion [36] to calculate the size-dependent diffusion coefficient
of lipid rafts and determine the difference in the diffusion
frequency of lipid rafts and signaling proteins unless otherwise
specified. This can ensure the rationality of our model in this
respect (see Appendix for details).
Then we increase the number of signaling proteins in
each lipid raft to investigate their accumulation effect within
these microdomains on the intercellular bond formation. As
described above, the raft affinity of Uaffinity → −∞ becomes
Uaffinity → +∞ for signaling proteins outside this raft if the
protein number inside that raft reaches a specified value Npro,
and the attempt for signaling proteins to enter into this raft
will be rejected. The raft number in each membrane is set to
be the protein number divided by this specified value Npro.
Consequently, at equilibrium each raft will carry the same
number of signaling proteins [Fig. 4(a)]. It is clearly seen
from Fig. 4(b) that the more the signaling proteins in each
lipid raft, the higher the membrane fraction Pb within binding
range. These results indicate that the protein accumulation
within lipid rafts facilitates the intercellular bond formation.
Meanwhile, compared with the case of the absence of lipid
rafts, a nonlinear relationship between Pb and u is presented
for Npro > 1. By increasing the number of signaling proteins,
it will result in the convergence phenomenon for large values
of u, which is especially apparent for small values of Npro, as
shown in Fig. 4(b).
Finally, to investigate the role of lipid rafts in the inter-
cellular TCR-pMHC interactions when the signaling proteins
are excluded from these microdomains, we perform subse-
quent simulations with the raft affinity of Uaffinity → +∞
[Fig. 5(a)]. The two apposing membranes contain the same
number of lipid rafts, which is determined by raft area and
size. Considering that lipid rafts are practically larger in size
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TABLE I. Simulation parameters for each figure. ncomponent denotes the number of membrane components, including signaling proteins and
lipid rafts in the T-cell membrane (T) and APC membrane (A). ρ is the ratio of diffusion coefficients of signaling proteins inside and outside
lipid rafts. Lraft (nm) is the side length of the square raft in the static raft model. Uαα is the attractive cis interactions of neighboring elementary
units of lipid rafts in the dynamic raft model and (Uαα)c is the critical raft-raft interaction strength for the occurrence of phase separation. Npro
is the protein number that each raft can carry. Araft is the raft area in the membranes. In Figs. 7–9, according to the experimental results, 50% of
total TCR molecules are set to reside in raft regions at equilibrium. The attempt to enter into a raft for TCRs in nonraft regions will be rejected
when the specified number of TCRs inside the total raft regions is reached. In Figs. 7, 9, 11, and 12, to prevent the lipid rafts being filled up
for high raft affinity Uaffinity → −∞, the pMHC molecules in nonraft regions are no longer allowed to enter into these microdomains when
they occupy 20% of the total raft regions.
Parameter
Static raft model Dynamic raft model
Figure number nTCR npMHC ρ Lraft(T) nraft(T) Lraft(A) nraft(A) Uαα(T) Uαα(A)
Fig. 2 200 60 0.01–1.0 50 200 50 60
Fig. 3 200 60 0.01–1.0 50 120 50 40
Fig. 4 50–350 50–350 0.01 50 nTCR/Npro 50 npMHC/Npro
Fig. 5 0.01 10–90 Araft(T)/L2raft(T) 10–90 Araft(A)/L
2
raft(A)
0.01 50 40 50 12Fig. 6 50 300 50 300
Fig. 7 0.01 50 120 10–90 Araft(A)/L2raft(A)
Fig. 8 0.01 50 120 10–180 Araft(A)/L2raft(A)
Fig. 9 200 60 0.01 1.7(Uαα)c 0–2.0(Uαα)c
Fig. 10 0.01 50 120 10–90 Araft(A)/L2raft(A)
Fig. 11 0.01 10–90 Araft(A)/L2raft(A) 0–2.0(Uαα)c
(a) 0.01 10–90 Araft(A)/L2raft(A)
(b) 0.01 0–2.0(Uαα)cFig. 12 (c) 0.01 10–90 Araft(A)/L2raft(A)
(d) 200–3000 60 0.01 10–90 Araft(A)/L2raft(A)
exclusion of proteins from lipid rafts promotes the intercellular
TCR-pMHC interactions. This result can be understood as fol-
lows. Considering a situation that the raft coverage area is fixed
at 50% of the membrane, the local protein concentration in
nonraft regions is doubled when the raft affinity is Uaffinity →
+∞. If the raft regions are occupied only by a single large raft,
it will be easier for signaling proteins to aggregate in nonraft
regions due to the poor size homogeneity, which favors in turn
the complex formation. The size homogeneity can be improved
if the single raft is divided into small ones. As a result, the
FIG. 3. Area concentration of pMHC molecules in lipid rafts and
TCR-pMHC complex fraction as a function of the parameters ρ and
φ for raft affinity of Uaffinity = –3kBT . The parameter values used
in the simulation are shown in Table I.
protein aggregation in nonraft regions will be weakened and
vanish when the uniform size of lipid rafts is the same as that of
signaling proteins. To quantitatively describe the aggregation
behavior of signaling proteins in nonraft regions, the pair












Here, npro and ρpro denote the total number and area
concentration of signaling proteins in each membrane,
respectively. The subscript “pro” can be either TCR or pMHC.
Ni(r) is the protein number at a given distance r from the
reference protein i. The pair distribution function gives the
probability of finding a pair of proteins separated by a distance
r. A larger value of g(r) means a higher probability of finding
a pair of proteins with a distance r. Specifically, g(r) = 1
stands for a random distribution of signaling proteins. As
shown in Fig. 5(c), the TCRs follow a random distribution in
the T-cell membrane for lipid rafts with side length of 10 nm
since the pair distribution function g(r) stays around the value
of 1. As the raft size increases, the value of g(r) is larger than
1 at smaller values of r. This result indicates that the proteins
tend to aggregate into a cluster for larger rafts. These results
are in conformity with the above analysis.
In essence, the reason for the positive impact of aggrega-
tion effect on the intercellular TCR-pMHC interactions lies
in binding cooperativity resulting from thermal membrane
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(a)
(b)
FIG. 4. (a) Snapshots of the equilibrium spatial distribution of
signaling proteins and lipid rafts for protein number in each raft
equaling 5. (b) Membrane fraction Pb within binding range as a
function of rescaled effective potential depth u for lipid rafts loaded
with different numbers of signaling proteins denoted by Npro. Here,
the dependence of Pb on u is obtained by varying the number of
signaling proteins in each membrane. For simplicity, the number of
TCRs is set to be the same as that of pMHC in that case. The raft
number is determined by the ratio of protein number and Npro. The
parameter values used in the simulation are shown in Table I.
effect weakens with increasing κ , and specifically, the positive
impact completely vanishes in the case of κ→ due to the
disappearance of membrane fluctuations (Fig. 6).
B. Lipid rafts can enhance the 2D in situ
TCR-pMHC interactions
In the following, a complete set of simulations based
on static and dynamic raft models will be performed
to explore the effect of lipid rafts on the interactions of
membrane-anchored TCR and pMHC molecules. According
to the experimental observations, lipid rafts are modeled to
represent 30% of the T cell membrane; 50% of total TCRs are
set to reside in raft regions at equilibrium [4,22,37]. Depending
on the detection methods, the lipid rafts in the T-cell membrane
vary widely in size. Here, we select a more recent consensus
value of 50 nm to define the dimension of lipid rafts in the
T-cell membrane [13,25,38–41]. Adopting the approach used
in experiments [27], we investigate the impact of lipid rafts on
the TCR-pMHC interactions by changing the characteristics
of lipid rafts on APCs. The number of proteins in a lipid raft
depends on the packing density, and thus, the protein number in
a raft may statistically scale with the raft size. But there exists




FIG. 5. (a) Snapshots of the equilibrium spatial distribution of
TCRs and lipid rafts for raft affinity Uaffinity → +∞ and raft making
up 35% of the T-cell membrane with different side lengths. (b) Effect
of the exclusion of signaling protein from lipid rafts on the complex
fraction for different raft sizes. (c) Pair distribution function g(r) as a
function of the distance r for raft making up 75% of the membranes
with raft side lengths ranging from 10 to 90 nm. The raft size and area
are set to be the same in T-cell and APC membranes in this figure.
The parameter values used in the simulation are shown in Table I.
raft 50 nm in diameter would probably carry no more than
10–30 proteins [4,42,43]. However, the lipid rafts may be
packed with signaling proteins for the extremely high raft
affinity in our model (i.e., Uaffinity → −∞, discussed below).
To prevent this, we need to specify a constraint condition.
In our static raft model, the lipid raft with size identical to
a single protein molecule will be filled up once a signaling
protein hops into this small microdomain. If we set a threshold
value of 0.2/a2 as the critical protein area concentration for
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FIG. 6. Influence of thermal membrane fluctuations on the
positive contribution made by the aggregation effect of signaling
proteins inside and outside lipid rafts. 	 is the ratio of the number
of TCR-pMHC complexes in the presence and absence of lipid rafts.
In case I, the equilibrium protein number in each raft is 5. In case II,
lipid rafts make up 75% of the T-cell and APC membranes with raft
affinity Uaffinity → +∞. The side length of the lipid rafts is 50 nm
in the two cases. The parameter values used in the simulation are
shown in Table I.
2a × 2a will fail to carry any signaling proteins. Considering
these actual situations, we define the finite protein-carrying
capability in terms of the protein area concentration in the total
raft coverage areas, rather than in an individual raft. Here, the
signaling proteins account for no more than 20% of total raft
coverage areas for high raft affinity Uaffinity → −∞. This
constraint applies to the dynamic raft model as well. We set
the parameter Uaffinity → −∞ to characterize the raft affinity
for proteins at the beginning of the simulation. The raft affinity
for proteins in nonraft regions becomes Uaffinity → +∞ if
the specified protein number in the total raft regions or the
protein-carrying capability of the total raft regions is reached.
In other words, the attempt to enter into a raft for TCRs in
nonraft regions will be rejected when the number of TCRs
inside the total raft regions is 100, and the rest of the pMHCs
outside lipid rafts are no longer allowed to enter into these
microdomains when their area concentration in the total raft
regions is 0.2/a2 [Fig. 7(b)].
Figure 7(a) shows our simulation result from the static
raft model that indicates a complicated interplay of lipid raft
characteristics on the intercellular TCR-pMHC interactions.
Taking into account the physical truth, we focus only on the
results for lipid rafts that are larger than signaling proteins.
We can clearly see that the TCR-pMHC complex fraction is
promoted to different extents as a function of the lipid raft
coverage and size. More specifically, the complex fraction
exhibits a striking biphasic relationship with raft coverage. The
number of TCR-pMHC complexes reaches its maximum value
when lipid rafts on APC exactly accommodate all pMHCs.
Meantime, we find that the correlation between the raft size
and the complex fraction is basically positive for lipid rafts
with size in the range of 20–90 nm.
These results shown in Fig. 7(a) are definitely attributed




FIG. 7. (a) TCR-pMHC complex fraction as a function of the raft
area ratio and raft size with parameters derived from experimental
measurements. The olive line shows the values obtained in the absence
of lipid rafts in the APC membrane. (b) Snapshots of the equilibrium
spatial distribution of pMHCs and lipid rafts for three different raft
areas marked with the numbers ©1 , ©2 , ©3 corresponding to those
in (a). The raft affinity is set as Uaffinity → −∞ at the beginning
of simulations. Here, the pMHCs are set to occupy at most 20% of
the total raft regions due to the finite protein-carrying capability. The
raft affinity for pMHCs in nonraft regions becomes Uaffinity → +∞,
and the pMHCs will not be allowed to enter into these microdomains
if the protein-carrying capability of the total raft regions is reached.
As a result, the equilibrium area concentration of pMHC in the total
raft regions has fixed at 0.2/a2 before the raft area is increased to a
value large enough to be capable of exactly adsorbing all the pMHC
molecules (©1 →©2 ). However, with further increase in raft area,
the equilibrium area concentration of pMHC within the total raft
regions decreases gradually (©2 → ©3 ). (c) Time sequence of spatial
distribution of signaling proteins and lipid rafts (©2 , top view). The
lipid rafts carrying TCRs on T cell at equilibrium incline to be located
in the membrane apposing the lipid rafts carrying pMHCs on APC.
The snapshots are taken at 103, 105, 106, and 107 MC steps. The final
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membranes due to the presence of lipid rafts. According to
the analysis in Sec. III A, the aggregation of signaling proteins
within lipid rafts can promote the formation of TCR-pMHC
complexes, whereas the resulting concentration decrease of
signaling proteins outside lipid rafts directly impairs the bond
formation in nonraft regions. The increased concentration of
TCR-pMHC complexes in the presence of lipid rafts indicates
that the net contribution made by the competing effects is
positive. With the increase in raft coverage for fixed raft size,
the positive net contribution to TCR-pMHC interactions is
enhanced, leading to the positive correlation between complex
fraction and raft area ratio for small raft coverage. After
the peak value of complex fraction is reached when all
pMHCs reside in lipid rafts, there will be a decrease in the
concentration of pMHCs in lipid rafts if further increasing raft
area [Fig. 7(b)]. The reduced concentration directly impairs
the aggregation effect of pMHCs inside lipid rafts, and in turn
results in a negative correlation between complex fraction and
raft area ratio for large raft coverage. Similarly, the change in
raft size will also induce competing effects on the complex
formation. On the one hand, decreasing the raft size for
fixed raft coverage can facilitate the TCR-pMHC interactions
by reducing the membrane roughness with more dispersive
anchor points to clamp the two membranes together; on the
other hand, it can impose a detrimental effect on the positive
contribution made by aggregation effect inside lipid rafts.
These factors compete and determine the raft-size-associated
behaviors. The results from Fig. 7(a) show that, in most cases,
the TCR-pMHC complex fraction increases with the raft size
(90 nm × 90 nm), implying the positive effects of increasing
raft size hold advantage. Additionally, according to the results
in Sec. III A, the intercellular TCR-pMHC interactions are
promoted when the signaling proteins are excluded from
lipid rafts and tend to aggregate in nonraft regions. This
positive contribution can also be affected by the raft area and
size. However, note that the raft occupying area in the APC
membrane used in Fig. 7(a) is relatively low (<15%); thus the
related effects on the complex formation can be negligible [see
Fig. 5(b)].
To determine what extent the lipid rafts can contribute
to the TCR-pMHC complex formation under physiologically
relevant conditions, we further perform simulations for lipid
rafts with larger size using the static raft model, considering
the experimental result that more than half of the total amount
of pMHCs is present in lipid rafts [27,44]. Figure 8(a) shows
that the TCR-pMHC complex fraction increases with the size
of lipid rafts on APC (180 nm) and the amount of pMHCs




that can be used to describe the strength of TCR-pMHC
interactions, is enhanced by, on average, two- to threefold
for 50%–100% of cell surface pMHCs residing in lipid rafts
in view of the typical raft size of 100–200 nm in diameter on
APCs [45–47]. Here, [RL] indicates the area concentration
of bound complexes. Moreover, it can even induce more than
a fivefold increase in the TCR-pMHC binding affinity for all
pMHCs residing in the lipid rafts with side length of 180 nm
if we simultaneously consider the contribution of the lipid
(a)
(b)
FIG. 8. (a) The extent to which lipid rafts facilitate the TCR-
pMHC bond formation as a function of raft size for different amounts
of pMHC in lipid rafts. According to the experimental results, lipid
rafts cover 10% of the APC surface [51]. The parameter values
used in the simulation are shown in Table I. (b) Snapshots of
the equilibrium spatial distribution of pMHCs and lipid rafts for
three concentrations of pMHCs in these microdomains. The pMHC
molecules in nonraft regions are no longer allowed to enter into lipid
rafts when the specified pMHC-carrying capability of the total raft
regions is reached.
rafts in the T-cell membrane. It has been well known that, as
a prominent feature of the TCR signal initiation machinery,
T-cell activation can be triggered by specific TCR recognition
of the very low density of pMHCs in physiological conditions,
but the underlying molecular mechanisms remain unclear. To
date, various models for T-cell antigen recognition at such low
density of pMHCs have been proposed, some of which have
highlighted the roles of the coreceptor assistance [48] and CD3
conformational change [49]. Serial engagement of a single
pMHC with clustered TCRs is also considered [50]. However,
in these previous works, the lipid raft-based regulation has not
been taken into account. Here, our results have borne out the
significant promotive effect of lipid rafts on the TCR-pMHC
binding affinity, which further extends the sustained interaction
time crucially required for a full activation of a T cell. Our
analysis might provide an alternative insight into the T-cell
antigen receptor triggering mechanisms.
We next investigate the role of lipid rafts in the intercellular
TCR-pMHC interactions using a dynamic raft model, in
which lipid rafts undergo dynamic rearrangement such as
merging and separating events modulated by the attractive cis
interaction Uαα they experience. Figure 9(a) shows the effect of
dynamic rafts on the formation of TCR-pMHC complex. The
attractive interaction between neighboring elementary units of

















FIG. 9. (a) TCR-pMHC complex fraction as a function of the
raft area ratio under five different attractive interaction values Uαα .
The olive line shows the values obtained in the absence of lipid
rafts in the APC membrane. (b) Time sequence of spatial distribution
of dynamic rafts experiencing attractive interaction Uαα = (Uαα)c for
different raft coverage areas. The snapshots are taken at 103, 105, 106,
and 5 × 107 MC steps. The final snapshots represent the equilibrium
state. (c) The average size of lipid rafts in the APC membrane as a
function of the raft area ratio under five different attractive interaction
values Uαα .
where (Uαα)c is the critical value of attractive interaction
Uαα for the occurrence of phase separation. Then we define
the average equivalent side length of lipid rafts as Lraft(A) =∑
ψjLj/
∑
ψj , which is about 50 nm at equilibrium for the
attractive interaction Uαα = 1.7(Uαα)c and the raft coverage
area of 30%. Here, ψj refers to the number of lipid rafts with
side length of Lj . For the range of parameter values used
here, the average size of lipid rafts on the APC membrane
increases with raft coverage area or attractive interaction Uαα;
see Fig. 9(c). As shown in Fig. 9(a), the TCR-pMHC complex
fraction is promoted for dynamic rafts with average size larger
than that of proteins due to the presence of attractive interaction
Uαα . In accordance with the results in Fig. 7(a), the complex
fraction increases with the average raft size characterized by
raft area ratio and Uαα before the critical raft area required for
exactly accommodating all pMHCs is reached [Fig. 9(a)]. The
trend of complex fraction with further increase in the raft area
shows either a positive or negative correlation, which depends
on the competition between the increased average raft size
and the decreased area concentration of pMHC molecules in
raft regions. A similar trend can be deduced from the data in
Fig. 7(a). Quantitatively, there is a difference in the complex
fraction obtained from the static and dynamic raft models,
even though the raft size in the static raft model is the same as
the average equivalent side length of lipid rafts in the dynamic
raft model. This may be attributed to the dynamic changes in
the size and shape of lipid rafts in the dynamic model.
Subsequently, in order to comprehensively investigate the
effect of lipid rafts on the TCR-pMHC interactions, we
consider a case that the lipid raft has a raft affinity of
Uaffinity = −3kBT . There is no longer constraint on the
protein area concentration in the total raft coverage areas
imposed in the case of Uaffinity → −∞. The diffusion ratio
r = 0.01 [52] is used to describe the difference in diffusivity of
signaling proteins inside and outside lipid rafts. The simulation
results from the static raft model reveal that the TCR-pMHC
complex fraction increases biphasically with the raft area.
Meanwhile, the promotive effect strongly depends on the raft
size ranging from 20 to 90 nm [Fig. 10(a)]. These results
are mainly attributed to the multiple, competing effects as
discussed in the case of Fig. 7(a). Additionally, comparing
the results in Fig. 10(a) with those in Fig. 7(a), we find that
the increasing intervals of complex fraction slightly increase
with the raft side lengths in the range of 20–90 nm. This
may be caused by the different area concentrations of pMHC
molecules in lipid rafts with different sizes. Our simulation
results, as expected, show that the area concentration of
pMHC molecules inside the total raft regions for different
raft coverage areas is independent of the raft size in the
absence of TCR-pMHC interactions. However, it reveals that
the area concentration of pMHC molecules within raft regions
increases with the raft side lengths ranging from 20 to 90 nm
in the presence of TCR-pMHC interactions. This is different
from the case in Fig. 7(a). In comparison with the smaller rafts,
the positive contribution made by the protein aggregation in
larger rafts can be more dominant when competing with the
negative contributors discussed in Sec. III B due to the higher
protein concentration within them. Then the increasing interval
of complex fraction for larger rafts is extended.
C. Lateral mobility of proteins on the substrate affects the role
of lipid rafts in the complex formation
The complexity of biological membranes and their inter-
actions with the surrounding media make it challenging to
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FIG. 10. (a) TCR-pMHC complex fraction as a function of the
raft area ratio and raft size for raft affinity of Uaffinity = –3kBT .
(b) The concentration of pMHC molecules in raft regions as a
function of the raft area ratio and size in the absence (Ubinding = 0)
and presence (Ubinding = 5.0kBT ) of TCR-pMHC interactions. The
parameter values used in the simulation are shown in Table I.
a wide variety of biomimetic model systems have been
developed. Among them, the 2D cell-substrate system has
been commonly used in different experimental techniques and
has provided significant new insights into the TCR recognition
of pMHC in immune responses [53].
The cell-substrate model is typically constituted of a flat
protein-containing lipid bilayer supported on a solid surface
such as mica, glass, or silicon. The lipids and proteins within
the supported membranes retain their lateral mobility which is
a crucial characteristic for these studies [54]. To probe the issue
concerned in this work, we adopt an experimental strategy
that APCs interact with TCRs’ functionalized supported
membranes, or vice versa. Importantly, the implications of
a costimulatory molecule on the TCR-pMHC interactions can
be eliminated comparing with the in situ measurement for live
T cells and APCs. This advantage, along with the tractability
and controllability of a solid-supported membrane model,
makes it possible to obtain more quantitative information on
the behaviors of the TCR-pMHC interactions in the presence
of lipid rafts. As shown in Fig. 11, the combined effects of
both increased effective bending rigidity and the lipid rafts
FIG. 11. The influence of lipid rafts on the TCR-pMHC interac-
tion for the cell-substrate model constituted of a flat TCR-containing
lipid bilayer supported on a solid substrate. The simulation results in
(a,b) are from the static and dynamic raft models, respectively. The
olive line shows the values obtained in the absence of lipid rafts in
the APC membrane. The parameter values used in the simulation are
shown in Table I.
that disappeared in the solid-supported membrane do not lead
to qualitative differences in the impact of lipid rafts on the
TCR-pMHC ligation. These results may provide the basis for
further experimental research.
Another commonly used cell-substrate model for probing
receptor-ligand interactions consists of a substrate presenting
immobilized proteins. Detailed information on the molecular-
binding properties has been derived from this simplified
model. Here, in order to study the impact of lipid rafts
on the TCR-pMHC interactions, we perform the following
simulations where the TCRs are fixed on the substrate. From
Figs. 12(a) and 12(b), it is surprising to find that the lipid
rafts adversely affect the formation of TCR-pMHC bonds. In
comparison with the case of Fig. 11, the complex fraction
exhibits an opposite trend with increasing raft coverage when
the side length of the lipid raft is larger than 10 nm. Meanwhile,
it reveals that the negative effect strongly depends on the raft
size. These intriguing phenomena could also be attributed to
the aggregation effect of lipid rafts on the membrane-anchored
proteins. Intuitively, the lateral mobility of pMHC molecules
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FIG. 12. Simulation results from the static (a) and dynamic (b) raft models showing the negative regulation of lipid rafts on the TCR-pMHC
interactions for the case of immobilized TCRs coated on the substrate. As in Figs. 7(a) and 9(a), the signaling proteins can occupy no more
than 20% of the total raft regions. (c) Detrimental effect of lipid rafts on the complex formation for cell-surface pMHCs and immobilized
TCRs in the case where raft affinity Uaffinity = –3kBT . (d) Complex fraction with respect to immobilized protein number and raft size for all
pMHCs residing in these microdomains. The area concentration of pMHC molecules in the total raft regions is 0.2/a2. The results in subfigures
(c,d) are obtained from the static raft model. The olive line shows the values obtained in the absence of lipid rafts in the APC membrane. The
parameter values used in these panels are shown in Table I.
which sterically interdicts their interactions with substrate-
immobilized TCRs outside the sphere of influence of the lipid
raft, thus preventing the bond formation. Likewise, the protein
aggregation outside lipid rafts will give rise to unfavorable
effects on the complex formation. The results presented in
Figs. 12(a) and 12(b) originate predominantly from lipid-
raft-induced change in membrane protein distribution, and
related effects have been discussed in Sec. III B. Consistently,
as a result of aggregation effect, the presence of lipid rafts
also shows a detrimental effect on the complex formation
where signaling proteins have more realistic raft affinity [see
Fig. 12(c)]. As expected, the inhibitory effect can be overcome
by grafting the substrate with a high density of immobilized
TCRs [Fig. 12(d)], because of the increased encounter and
rebinding probabilities which weaken the negative impact of
protein aggregation. Using this kind of cell-substrate model,
Murai et al. [28] experimentally examined the case that
T cells were perfused across hyaluronan-coated microtiter
plates and conversely suggested that the presence of lipid
rafts in the T-cell membrane suppresses cell adhesion and
migration. Combined with the modeling results, we provide
an explanation for this discrepancy regarding the role of lipid
rafts in the receptor-ligand interactions. One should notice that,
to investigate the effect of lipid rafts on the receptor-ligand
interactions, Anderson et al. [27] and Murai et al. [28] used
two different systems in which the interacting partners are TCR
and pMHC, and CD44 and hyaluronan, respectively. This,
however, may involve other potential underlying mechanisms
accounting for the discrepancy. Alternatively, as speculated
by Murai et al. [28], disruption of lipid rafts may trigger
the conformational change that alters the hyaluronan-binding
ability of CD44, which needs to be further studied.
In addition to the cell-substrate model, Murai et al. [28]
also experimentally studied the effect of lipid rafts on
the intermolecular interactions between membrane-anchored
CD44 and in-solution hyaluronan. They showed that the
hyaluronan-binding ability of CD44 in T cells is upregulated
by raft disruption. Employing a stochastic MC algorithm,
Caré and Soula [55] also found that the complex formation
on the cell surface is inhibited by the presence of lipid
rafts in this kind of receptor-ligand interaction. For binding
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receptors, there is no external force acting on the receptor-
ligand complexes, whereas the 2D in situ receptor-ligand
interaction will be negatively affected by the entropic repulsive
force arising from thermally excited membrane fluctuations,
as receptors and ligands anchor on two apposing surfaces. As
discussed above, the presence of lipid rafts can lead to protein
aggregation, which in turn promotes the 2D interactions
essentially due to the fluctuation-induced cooperative binding
of membrane-anchored receptors and ligands. Based on our
current simulation results, we speculate that it may be the
thermal membrane fluctuations that account for the contradic-
tory results concerning the impact of lipid raft on the receptor-
ligand interactions obtained by the two measurement methods.
Additionally, in the experiments of Anderson et al. [27]
and Murai et al. [28], MβCD is used to extract the membrane
cholesterol to investigate the role of lipid rafts in the
receptor-ligand interactions. It is generally believed that
MβCD-induced cholesterol depletion will lead to a decrease
in the bending rigidity of the membranes [56–58], which in
turn enhances the thermal fluctuations of the membranes.
Thus the raft-disrupting agent, MβCD, plays a negative
regulation role in the 2D receptor-ligand interactions from
this perspective. However, more studies reveal that the effect
of cholesterol depletion on the membrane bending rigidity
is not universal but rather depends on the cell type and lipid
architecture [59–62]. Therefore, the potential contributions of
MβCD to the receptor-ligand interactions may be specific to
the type of cells and lipids.
IV. CONCLUSIONS
Using a statistical-mechanical membrane model, we have
investigated the impact of lipid rafts on the interactions
between TCR and pMHC under different experimental con-
ditions. We show that whether the contribution of lipid rafts
to TCR-pMHC interactions is positive or negative depends
strongly on the measurement methods. For the case of in situ
molecular interactions where TCR and pMHC are anchored on
the 2D membranes of the apposing cells, our results are consis-
tent with the experimental data indicating that the presence of
lipid rafts facilitates the intercellular TCR-pMHC interactions.
We attribute the enhanced intercellular interactions to the
lipid-raft-induced aggregation effect and thermal membrane
fluctuations, which provides us with an alternative mecha-
nism for lipid-raft-mediated regulation of intercellular signal
transduction. Further quantitative analysis reveals a significant
increase in the binding affinity of membrane-anchored TCR
and pMHC under physiological conditions, which may provide
an alternative insight into the mechanism of efficient T-cell
activation at a very low density of pMHCs. In the cell-substrate
models, our results indicate that the preservation of lateral
mobility of signaling proteins on the solid substrate is indis-
pensable for bringing into play the positive role of lipid rafts in
facilitating TCR-pMHC interactions. Conversely, we find that,
as a result of the immobilization of proteins on the substrate,
protein aggregation induced by the presence of lipid rafts will
function as a negative regulatory mechanism for the complex
formation. These findings help to illuminate the seemingly
contradictory experimental results. This study enriches our
understanding of the functional implications of lipid rafts for
the adaptive immune responses and suggests that we should
prudently choose the experimental methods when measuring
the impact of lipid rafts on the receptor-ligand interactions.
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APPENDIX: MODEL AND SIMULATION METHOD
We use a statistical-mechanical membrane model [63]
in which two membranes are interconnected by membrane-
anchored receptors (TCRs) and ligands (pMHCs). The lipid
rafts can freely diffuse in the membranes.
1. Discretized membrane model and TCR-pMHC interactions
In the Monte Carlo (MC) simulation, we employ a dis-
cretized membrane model in which the spatial coordinates
are replaced by a square grid with lattice site i and lattice
constant a, and the local separation describing the membrane
conformations is specified by li . The membranes can collide,
but cannot overlap, so that li  0. The repulsive hard-wall
interaction is implicitly embodied via the interaction potential,
Wmem(li) = ∞ for li < 0 and zero otherwise, (A1)
which induces the Helfrich entropic force [29,64]. The linear
lattice size a is set to be 10 nm to roughly follow the size of the
TCR and pMHC [65]. Each lattice can contain a single signal-
ing protein. Each TCR or pMHC in a certain lattice can hop
by a distance of one lattice spacing to one of the four nearest-
neighbor lattices with equal probability during a single time
step, provided that the available lattice is unoccupied by other
molecules. The repulsive hardcore cis interaction between two
neighboring TCRs or pMHCs at sites i and j , which leads to
their mutual exclusion within the membrane, has the form
Wpro(i,j ) = ∞ for i = j and zero otherwise. (A2)
In our model, whether a TCR-pMHC binding event occurs
or not depends on the distribution of signaling proteins in each
membrane patch and the local separation of binding sites [66].
The membrane configurations are then regulated by its bending
rigidity and the specific TCR-pMHC interaction. Conse-
quently, the effective Hamiltonian for the two fluctuating mem-
branes interconnected by TCRs and pMHCs can be given by
H {l,m,n} = Hel{l,m,n} + Hint−pro{l,m,n}
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which is the essential element required for subsequent MC
simulations. Here, κ and dli denote the effective bending
rigidity and standard discretized Laplacian, respectively. mi
(ni) describes the distribution of signaling proteins. If mi
(ni) = 1, it means that there is a TCR (pMHC) in lattice i;
otherwise, mi (ni) = 0. We consider the square-well potential
with the depth Ubinding > 0 and the range lv to characterize
the TCR-pMHC interaction,
V (li) = −Ubindingθ (lv/2 − |li − lc|), (A4)
which is defined by a step function: θ (x) = 1 for x  0, and
θ (x) = 0 otherwise.
2. Lipid raft model
Lipid rafts are liquid-ordered microdomains with less
fluidity that diffuse freely within the surrounding liquid-
disordered membrane bilayer. Based on these properties
associated with lipid rafts, we assign areas with low diffusivity
as raft regions on the discretized membranes. The extent of the
slowdown diffusion behavior of signaling proteins inside lipid
rafts can be characterized by the diffusion coefficient ratio
ρ = Draft/Dnonraft [30,31], where Draft and Dnonraft represent
the step size of signaling proteins inside and outside lipid
rafts, respectively. Obviously, the smaller the ratio ρ, the more
slowly the signaling proteins diffuse in lipid rafts. In our study,
the unit step size for signaling proteins in raft and nonraft
regions is set to be ρ and one lattice, respectively. In our study,
the lipid rafts are assumed to diffuse in a manner analogous
to the proteins. Note that we use a Markov process to generate
the random set of states in the MC simulations. An important
condition we require for a Markov process is the condition of
detailed balance. To satisfy this condition, the lipid rafts move
independently of the signaling proteins in each membrane.
This is somewhat different from the simulation process in
Refs. [30,31] where the proteins residing in the lipid rafts
move along with these microdomains. Similarly, to ensure
volume exclusion and prevent overlaps of lipid rafts, repulsive
hard-square interaction between microdomains is imposed,
given by
Wraft = ∞ for raft - raft overlaps and zero otherwise, (A5)
and the lateral diffusion of the lipid raft is only carried out
when the target patches are not occupied by other rafts.
To reveal the impact of lipid rafts on the TCR-pMHC
interaction, we employ two types—static and dynamic—
of lipid raft models. In the case of the static raft model, lipid
rafts are modeled as square-shaped microdomains with defined
sizes. The cis interaction between lipid rafts only includes the
repulsive hard-square interaction, and there is no change in
shape and size throughout the MC simulation. According to
the Saffman-Delbrück equation [36], the ratio of the diffusion
coefficients of microdomains (Dr ) and signaling proteins (Dp),
















where the viscosity of the fluid membrane μ = 1 poise, the
viscosity of the surrounding aqueous phase μ′ = 0.01 poise,
the Euler’s constant γ = 0.5772 [36], the thickness of the
membranes h and the radius of the signaling proteins r are
set to be 5 nm [67], and r̄ denotes the equivalent radius of
the square-shaped lipid rafts. For example, if Dr/Dp = 0.8,
a lipid raft has a probability of 0.8 to diffuse laterally and a
probability of 0.2 not to move at all during a simulation step.
Lipid rafts in vivo are highly dynamic microdomains with a
broad size distribution on the membranes. Additionally, lipid
rafts undergo many merging and separating events during their
lifetime [68]. Here, we present a dynamic raft model to mimic
these processes, in which lipid rafts experience attractive cis
interactions between them. Hu et al. [69] have adopted similar
model to study the morphologies of thermally fluctuating
vesicles. In general, the interaction energy of neighboring





where 〈ij 〉 denotes a nearest-neighbor pair of membrane
patches and Uij is the corresponding interaction energy for
each pair. Here, we use the notation α and β to denote
the raft and nonraft membrane patches, respectively. Each
nearest-neighbor pair is one of the three types (αα), (ββ),
or (αβ). Letting the respective numbers of such pairs be Nαα ,
Nββ , Nαβ , Eq. (A7) becomes
Hint−pat = NααUαα + NββUββ + NαβUαβ. (A8)
Considering the two-dimensional square-lattice geometry,
we have the relations
4Nα = 2Nαα + Nαβ,
(A9)
4Nβ = 2Nββ + Nαβ,
where Nα and Nβ are the total number of α and β squares,
respectively. According to Eq. (A9), the interaction energy of
membrane patches in Eq. (A8) can be written as
Hint−pat = Nαβ
[
Uαβ − 12 (Uαα + Uββ)
] + 2[NαUαα + NβUββ],
(A10)
where the last term on the right-hand side of the above equation
is a constant. Then, the interaction energy Hint−pat depends
only on the value of Nαβ . Comparison of Eq. (A10) with the
results from the Ising model without an external magnetic field
immediately leads to the correspondence
Uαβ − 12 (Uαα + Uββ) = 2J, (A11)
where J is the interaction energy between nearest-neighbor
spins. With the exact critical value Jc/kBT = ln(1 +
√
2)/2 for
lateral phase separation in the square-lattice Ising model [70],
we get the relation
[Uαβ − (Uαα + Uββ)/2]c = ln(1 +
√
2)kBT . (A12)
If Uαβ = 0 and Uββ = 0, one can obtain the critical raft-raft
interaction strength,
(Uαα)c = −2 ln(1 +
√
2)kBT . (A13)
Equation (A13) provides an important reference value for
modeling the phase behavior of lipid rafts. In the dynamic raft
model, the elementary unit of lipid rafts is set to be a square
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of lipid rafts by varying cis-interaction energy, Uαα , near its
critical value, (Uαα)c. The effective Hamiltonian of the system
is then given by








miniV (li) + Wmem(li)




It should also be pointed out that, with regard to the
formation of lipid rafts, there are a number of theoretical and
computational models to mimic and elucidate the dynamic
processes. Veatch et al. [71] suggested that compositional
fluctuations at transient temperature are the origins of mi-
crodomain formation. Fan et al. [72] explained the formation
of lipid rafts by studying the nonequilibrium lipid transport
processes. Additionally, many studies emphasized the crucial
roles of protein-lipid and protein-protein interactions in the
formation and regulation of lipid rafts [73,74]. For more details
on different models of raft formation, see Refs. [68,75]. These
theories and models offer new insights for plasma membrane
heterogeneity and provide alternative modeling perspectives
for the dynamic simulations of lipid rafts.
One of the most important properties of lipid rafts is that
they may include or exclude proteins. To simulate the raft
affinity, we introduce a parameter Uaffinity to define the
corresponding change in the energy for a signaling protein in
nonraft regions entering into a lipid raft. Then the acceptance
probability of the hopping process of the signaling proteins
between nonraft and raft regions is determined by the Metropo-
lis algorithm described below. In addition, the diffusion of a
lipid raft may lead to a change in the energy by including or
excluding signaling proteins. This process should also follow
the standard Metropolis criterion. Particularly, once hopping
into a lipid raft, a signaling protein will be permanently
captured for Uaffinity → −∞ through its hopping process.
In our model, the signaling proteins and lipid rafts are
randomly sampled to undergo diffusion during each MC step.
However, such sampling procedures will involve the unequal
probability selection when there is a difference in the number
of signaling proteins and lipid rafts, causing the TCRs and
pMHCs, as well as lipid rafts, to fail to diffuse accurately
according to the physical relations determined by the Saffman-
Delbrück equation [36]. To address this problem, we can make
use of the number ratios of signaling proteins and lipid rafts
in the membranes of APC and T cell: RTCR = nTCR/ntotal,
RpMHC = npMHC/ntotal, RA = nraft(A)/ntotal, RT = nraft(T)/ntotal,
together with a random number R between 0 and 1. Only if
the condition R < Rcomponent is satisfied can the corresponding
component be chosen to attempt to move. Here, the subscript
“component” can be either a signaling protein or a lipid raft in
each membrane.
3. Characteristic time scales associated with physical processes
Importantly, we should take seriously the characteristic
time scales associated with physical processes in our model.
According to the two-dimensional diffusion law t = a2/4D,
the characteristic hop time of signaling proteins on the length
scale α = 10 nm is on the order of 2 ms with the typical
diffusion constant D ≈ 10−10 cm2/s for membrane-anchored
proteins [76], while the characteristic relaxation time for
membrane shape fluctuations on this length scale is around
0.2 ms [77], tenfold smaller than that protein diffusion time.
To handle this disparity in characteristic time scales, we
perform simulations with, on average, ten attempted local
moves per patch before all signaling proteins attempt to diffuse
laterally once. Subsequently, each lipid raft will undergo
the hopping process with a probability determined by the
Saffman-Delbrück equation [36].
4. Metropolis MC method
In order to investigate the role of the lipid raft on the
TCR-pMHC ligation, we employ standard Metropolis MC
simulations for the model defined by Eq. (A14). During the
simulations, both the fluctuations of membranes and the lateral
diffusion of signaling proteins and lipid rafts may lead to a
change in configurational energy of the system. Following
the Metropolis criterion, the local fluctuation or the lateral
diffusion is always accepted if the change in configurational
energy H is negative, but is accepted with the probability
exp(−H/kBT ) for H > 0.
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